{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:46:47Z","timestamp":1763016407761},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2003,6,1]]},"DOI":"10.1038\/sj.bmt.1704062","type":"journal-article","created":{"date-parts":[[2003,6,10]],"date-time":"2003-06-10T06:43:24Z","timestamp":1055227404000},"page":"1089-1095","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor"],"prefix":"10.1038","volume":"31","author":[{"given":"H G","family":"Sayer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Kiehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S A","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Schaefer-Eckart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Schwerdtfeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Siegert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Runde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Theuser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Schetelig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D W","family":"Beelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Fauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Kienast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"H\u00f6ffken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Ehninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bornh\u00e4user","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Cooperative German Transplant Study Group (CGTG)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,6,10]]},"reference":[{"key":"BF1704062_CR1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1182\/blood.V79.2.313.313","volume":"79","author":"PH Wiernik","year":"1992","unstructured":"Wiernik PH, Banks PLC, Case Jr DC et al. Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia. Blood 1992; 79: 313\u2013319.","journal-title":"Blood"},{"key":"BF1704062_CR2","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1182\/blood.V87.5.1710.1710","volume":"87","author":"JF Bishop","year":"1996","unstructured":"Bishop JF, Matthews JP, Young GA et al. A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood 1996; 87: 1710\u20131717.","journal-title":"Blood"},{"key":"BF1704062_CR3","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJM199812033392301","volume":"339","author":"PA Cassileth","year":"1998","unstructured":"Cassileth PA, Harrington DP, Appelbaum FR et al. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med 1998; 339: 1649\u20131656.","journal-title":"N Engl J Med"},{"key":"BF1704062_CR4","first-page":"13","volume":"17","author":"F Frassoni","year":"1996","unstructured":"Frassoni F, Labopin M, Gluckman E et al. Results of allogeneic bone marrow transplantation for acute leukaemia have improved over time in Europe. Bone Marrow Transplant 1996; 17: 13\u201318.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704062_CR5","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1182\/blood.V76.9.1867.1867","volume":"76","author":"R Cift","year":"1990","unstructured":"Cift R, Buckner C, Appelbaum F et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood 1990; 76: 1867\u20131871.","journal-title":"Blood"},{"key":"BF1704062_CR6","first-page":"255","volume":"4","author":"I Auer","year":"1991","unstructured":"Auer I, Gale R . Are new conditioning regimens for transplantation in acute myelogenous leukemia better? Bone Marrow Transplant 1991; 4: 255\u2013262.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704062_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2141.1993.tb04622.x","volume":"83","author":"JA Yin","year":"1993","unstructured":"Yin JA, Johnson PRE . Clinical annotation. Acute myeloid leukaemia in the elderly: biology and treatment. Br J Haematol 1993; 83: 1\u20136.","journal-title":"Br J Haematol"},{"key":"BF1704062_CR8","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","volume":"300","author":"P Weiden","year":"1979","unstructured":"Weiden P, Flournoy N, Thomas E et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979; 300: 1068\u20131073.","journal-title":"N Engl J Med"},{"key":"BF1704062_CR9","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman J et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 1995; 86: 2041\u20132050.","journal-title":"Blood"},{"key":"BF1704062_CR10","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","volume":"97","author":"PA McSweeney","year":"2001","unstructured":"McSweeney PA, Niederwieser D, Shizuru JA et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390\u20133400.","journal-title":"Blood"},{"key":"BF1704062_CR11","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"89","author":"S Giralt","year":"1997","unstructured":"Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89: 4531\u20134536.","journal-title":"Blood"},{"key":"BF1704062_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1182\/blood.V99.1.75","volume":"99","author":"P Corradini","year":"2002","unstructured":"Corradini P, Tarella C, Olivieri A et al. Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies. Blood 2002; 99: 75\u201382.","journal-title":"Blood"},{"key":"BF1704062_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1182\/blood.V97.3.631","volume":"97","author":"S Giralt","year":"2001","unstructured":"Giralt S, Thall PF, Khouri I et al. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood 2001; 97: 631\u2013637.","journal-title":"Blood"},{"key":"BF1704062_CR14","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek Y et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756\u2013763.","journal-title":"Blood"},{"key":"BF1704062_CR15","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1182\/blood.V96.7.2419","volume":"96","author":"DP Kottaridis","year":"2000","unstructured":"Kottaridis DP, Milligan DW, Chopra R et al. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood 2000; 96: 2419\u20132425.","journal-title":"Blood"},{"key":"BF1704062_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.bmt.1700851","volume":"20","author":"HD Ottinger","year":"1997","unstructured":"Ottinger HD, Albert E, Arnold R et al. German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cell. Bone Marrow Transplant 1997; 20: 101\u2013105.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704062_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457\u2013462.","journal-title":"J Am Stat Assoc"},{"key":"BF1704062_CR18","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V96.12.3948","volume":"96","author":"A Venditti","year":"2000","unstructured":"Venditti A, Buccisano F, Del Poeta G et al. Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukaemia. Blood 2000; 96: 3948\u20133952.","journal-title":"Blood"},{"key":"BF1704062_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/sj.bmt.1702519","volume":"26","author":"J Sierra","year":"2000","unstructured":"Sierra J, Storer B, Hansen JA et al. Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience. Bone Marrow Transplant 2000; 26: 397\u2013404.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704062_CR20","first-page":"1254","volume":"96","author":"MS Tallman","year":"2000","unstructured":"Tallman MS, Rowlings PA, Milone G et al. Effect of postremission chemotherapy before human leukocyte antigen- identical sibling transplantation for acute myelogenous leukemia in first complete remission. Blood 2000; 96: 1254\u20131258.","journal-title":"Blood"},{"key":"BF1704062_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJM200101183440303","volume":"344","author":"WI Bensinger","year":"2001","unstructured":"Bensinger WI, Martin PJ, Storer B et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175\u2013181.","journal-title":"N Engl J Med"},{"key":"BF1704062_CR22","first-page":"477a","volume":"98","author":"JP Panse","year":"2001","unstructured":"Panse JP, Heimfeld S, Guthrie KA et al. Effect of PBSC graft-composition on T-cell chimerism, rejection and outcome in non-myealoablative HSCT: NK-cells predict for T-cell engraftment. Blood 2001; 98: 477a [Abstr.].","journal-title":"Blood"},{"key":"BF1704062_CR23","first-page":"2254","volume":"7","author":"M Bornh\u00e4user","year":"2001","unstructured":"Bornh\u00e4user M, Thiede C, Platzbecker U et al. Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients. Clin Cancer Res. 2001; 7: 2254\u20132262.","journal-title":"Clin Cancer Res"},{"key":"BF1704062_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1056\/NEJM199907013410103","volume":"341","author":"G Soci\u00e9","year":"1999","unstructured":"Soci\u00e9 G, Stone JV, Wingard JR et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. N Engl J Med 1999; 341: 14\u201321.","journal-title":"N Engl J Med"},{"key":"BF1704062_CR25","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1046\/j.1365-2141.2001.03135.x","volume":"115","author":"S Maury","year":"2001","unstructured":"Maury S, Mary JY, Rabian C et al. Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol 2001; 115: 630\u2013641.","journal-title":"Br J Haematol"},{"key":"BF1704062_CR26","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1200\/JCO.2001.19.14.3340","volume":"19","author":"M Michallet","year":"2001","unstructured":"Michallet M, Bilger K, Garban F et al. Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome. J Clin Oncol 2001; 19: 3340\u20133349.","journal-title":"J Clin Oncol"},{"key":"BF1704062_CR27","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1182\/blood-2002-02-0400","volume":"100","author":"R Martino","year":"2002","unstructured":"Martino R, Caballero MD, Peres Simon JA et al. Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes. Blood 2002; 100: 2243\u20132245.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704062","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:47:42Z","timestamp":1648064862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,1]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,6,1]]}},"alternative-id":["BF1704062"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704062","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2003,6,1]]},"assertion":[{"value":"5 December 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}